| Y/e 31 Mar | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 32 | 18.86 | 25.87 | 15.84 |
Op profit growth | 28.52 | 26.97 | 30.14 | 11.6 |
EBIT growth | 23.08 | 25.96 | 24.28 | 12.26 |
Net profit growth | 18.24 | 29.06 | 32.31 | 10.73 |
Profitability ratios (%) | ||||
OPM | 26.86 | 27.59 | 25.82 | 24.97 |
EBIT margin | 24.2 | 25.95 | 24.49 | 24.8 |
Net profit margin | 16.51 | 18.44 | 16.98 | 16.15 |
RoCE | 28.85 | 33.02 | 35.18 | 37.62 |
RoNW | 6.27 | 6.4 | 6.2 | 6.17 |
RoA | 4.92 | 5.86 | 6.1 | 6.12 |
Per share ratios (₹) | ||||
EPS | 42.03 | 35.57 | 27.31 | 20.61 |
Dividend per share | 12 | 20 | 12 | 4.5 |
Cash EPS | 28.4 | 25.72 | 18.37 | 16.52 |
Book value per share | 180.18 | 149.4 | 123.92 | 94.54 |
Valuation ratios | ||||
P/E | 62.03 | 76.11 | 51.31 | 42.44 |
P/CEPS | 91.79 | 105.23 | 76.27 | 52.93 |
P/B | 14.47 | 18.12 | 11.3 | 9.25 |
EV/EBIDTA | 35.29 | 44.68 | 27.87 | 23.63 |
Payout (%) | ||||
Dividend payout | 33.55 | 33.98 | 53.03 | 8.77 |
Tax payout | -26.25 | -24.82 | -26.7 | -34.26 |
Liquidity ratios | ||||
Debtor days | 13.29 | 13.62 | 12.69 | 14.32 |
Inventory days | 8.31 | 11.48 | 11.56 | 7.81 |
Creditor days | -38.88 | -45.56 | -38.88 | -31.46 |
Leverage ratios | ||||
Interest coverage | -16.73 | -25.64 | -21.27 | -311.71 |
Net debt / equity | -0.05 | -0.62 | -0.55 | -0.39 |
Net debt / op. profit | -0.15 | -1.77 | -1.65 | -1.18 |
Cost breakup (₹) | ||||
Material costs | -24.06 | -25.12 | -22.45 | -21.38 |
Employee costs | -17.48 | -17.3 | -18.23 | -17.1 |
Other costs | -31.59 | -29.97 | -33.48 | -36.53 |
Dr Lal PathLabs declared a fourth interim dividend of ₹6 per share for 2025, reflecting its strong cash generation and shareholder remittance focus.
The company declared a third interim dividend of ₹6 per share (60% on a face value of ₹10) for FY25.
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
